Windtree Therapeutics (WINT), a biotech firm listed on Nasdaq, has recently made headlines by venturing into the cryptocurrency space, particularly focusing on Binance Coin (BNB).
Just over a week after raising…
Windtree Therapeutics, a biotechnology company specializing in oncology and cardiovascular treatments, announced a new $520 million funding package to support a cryptocurrency treasury strategy focused on BNB token acquisition. According to…